BioSpace News Archive

BioMidwest

Bright Health Announces 2020 Plan Details and Pricing for New York City

Bright Health will continue offering plans in the boroughs of Brooklyn, Queens and Manhattan.

October 3, 2019
·
6 min read
BioMidwest

Bright Health Announces Ohio Expansion in 2020 Including a New Collaboration with University Hospitals

Beginning in 2020, Bright Health will offer Medicare Advantage plans for the first time to Cleveland-Akron area residents through a new partnership with University Hospitals.

October 3, 2019
·
7 min read
Policy

Biocept Announces Issuance of South Korean Patent Covering its Target Selector™ Oncogene Mutation Enrichment and Detection Platform

Expands intellectual property to 37 issued patents globally for highly sensitive methods of detecting cancer biomarkers

October 3, 2019
·
5 min read
Genetown

Verve Therapeutics Appoints Cardiologist Andrew Bellinger, M.D., Ph.D., as Chief Scientific Officer

Dr. Bellinger’s wide-ranging scientific expertise includes biomedical engineering and drug delivery, computational modeling, pharmacology, clinical strategy and translational medicine.

October 3, 2019
·
3 min read
Job Trends

SkinTE Data to be Presented at the 19th Annual Diabetic Foot Global Conference

PolarityTE, Inc. announced that two abstracts demonstrating the impact of the Company’s SkinTE™ product in treating diabetes-related wounds were accepted for poster presentations at the 2019 Diabetic Foot Global Conference

October 3, 2019
·
5 min read
Biotech Bay

Aeovian Pharmaceuticals Raises $37 Million Series A Financing to Advance Selective mTORC1 Inhibitors into the Clinic for Rare and Age-Related Diseases

venBio Partners and Sofinnova Investments co-lead Series A round alongside Apollo Health Ventures with Evotec SE joining the current round

October 3, 2019
·
4 min read
Genetown

AVROBIO, Inc. to Present at Chardan’s 3rd Annual Genetic Medicines Conference

AVROBIO, Inc. announced that Geoff MacKay, President and CEO of AVROBIO, will present at Chardan’s 3rd Annual Genetic Medicines Conference on Monday, October 7, 2019.

October 3, 2019
·
1 min read
Drug Development

Oncternal Therapeutics Announces Opening of Phase 1b Expansion Cohort of Clinical Trial of Cirmtuzumab in Combination with Ibrutinib in Patients with Mantle Cell Lymphoma

Cirmtuzumab combination demonstrated clinical activity with complete responses in mantle cell lymphoma

October 3, 2019
·
8 min read
Policy

Biodesix Secures U.S. Patent for Proprietary Blood Specimen Collection Device

Innovative New Device Enhances Ease of Use and Reduces Cost and Environmental Impact of Blood Sample Collection, Processing, and Shipping

October 3, 2019
·
3 min read
Horizon Therapeutics plc Named One of the Best Adoption-Friendly Workplaces by the Dave Thomas Foundation for Adoption

The list recognizes organizations with the most robust adoption benefit programs, comparing financial reimbursement and paid leave offered to employees who adopt, based on a survey of organizations across the United States.

October 3, 2019
·
2 min read